🇺🇸 FDA
Patent

US 9284411

Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds

granted A61KA61K9/1272

Quick answer

US patent 9284411 (Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds) held by Serina Therapeutics, Inc. expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K9/1272